Mathai Mammen - Feb 14, 2022 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Role
EVP, Pharm, R&D
Signature
Raavi Deol, as attorney-in-fact for Mathai Mammen
Stock symbol
JNJ
Transactions as of
Feb 14, 2022
Transactions value $
-$394,265
Form type
4
Date filed
2/15/2022, 07:03 PM
Previous filing
Jan 13, 2022
Next filing
Jun 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JNJ Common Stock Options Exercise $0 +7.42K +22.84% $0.00 39.9K Feb 14, 2022 Direct F1
transaction JNJ Common Stock Tax liability -$394K -2.34K -5.85% $168.85 37.6K Feb 14, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JNJ Restricted Share Units Options Exercise $0 -7.42K -100% $0.00* 0 Feb 14, 2022 Common Stock 7.42K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.
F2 Shares withheld for payment of taxes upon vesting of Restricted Share Units.